Cent

Healthcare AI

Detects life-threatening diseases at 'Stage 0' or 'Stage 1' when survival rates are exponentially higher, through comprehensive multi-modal screening (full-body MRI, CT, DEXA, 120+ biomarkers, genetics) with AI-powered synthesis, identifying 300+ conditions responsible for 80%+ of premature deaths with 26% clinically meaningful detection rate in initial scans.

📍 Bengaluru, India
📅 Founded 2023
🌐 Visit Website

🔍 Company Overview

An AI-powered preventive healthcare intelligence platform focused on early detection of cancer, cardiac, neurological, and metabolic (CCNM) diseases before symptoms appear, using multi-modal imaging, biomarkers, and AI synthesis.

📈 Current Stage
Seed-funded startup with $5M raised; launching specialized early detection centers in Bengaluru, Mumbai, and Delhi starting March-April 2026
🎯 Target Customers
Direct-to-consumer (D2C) asymptomatic individuals aged 30+ seeking proactive health screening; health-conscious adults focused on preventive care and longevity; high-net-worth individuals and executives prioritizing comprehensive health monitoring
🏢 Industry Verticals
Preventive Healthcare, Medical Diagnostics, Healthcare AI, Health Screening & Wellness, Medical Imaging, Diagnostic Imaging Centers

👥 Leadership & Team

👤 CEO
Shashank ND
💼 CEO Experience
Founder & CEO of Practo (2008-present), India's leading healthcare technology platform. Founded Practo as a college project and scaled it to serve 200M+ users across 15 countries. Expertise in healthcare technology, digital health platforms, and AI-driven healthcare solutions. Featured in Forbes 30 Under 30 Asia (2017). Economic Times Startup of the Year recognition. Now Founder & Chair of Cent, focused on AI-powered preventive health intelligence.
🌟 Key Team Members
Arpit Garg (Co-founder & Chief AI and Research Officer, former Head of Product at Lenskart), Anshul Khandelwal (Co-founder & Chief Business Officer, former CMO at Ola Electric), Dr. Nandakumar K (Chief Radiologist with 25+ years imaging expertise)

🏆 Achievements & Milestones

  • • Founded in 2023 by Practo co-founder Shashank ND with experienced team from Lenskart and Ola Electric
  • • Developed proprietary CCNM™ protocol for screening 300+ conditions
  • • Conducted 1,500+ scans during initial operations with strong detection rates
  • • Raised $5M seed funding from OneFlow Holdings and South Park Commons (Mar 2026)
  • • Official launch announced Mar 6, 2026 following months of live operations
  • • Planning to launch specialized centers in Bengaluru, Mumbai, and Delhi starting Mar-Apr 2026

📦 Products & Solutions

Key Products
CCNM™ Protocol (Cardiac, Cancer, Neurological, Metabolic Screening), Full-Body MRI Scan, CT Calcium Scoring for Heart Blockage Detection, DEXA Body Composition & Bone Density Analysis, Blood X: 120+ Biomarker Analysis, Tru10™ Organ-Wise Health Scoring System, AI-Powered Health Intelligence Dashboard, Genetic Risk Mapping Module (Add-On), Doctor-Reviewed Reports with Specialist Consultation, At-Home Blood & Urine Collection Service
Unique Value Proposition
Pioneers 'zero-symptom' diagnostics focused exclusively on pre-symptomatic disease detection at Stage 0/Stage 1, combining full-body MRI, low-dose CT, DEXA, ECG, 120+ biomarkers, and optional genetic testing into a single standardized workflow. Proprietary CCNM™ protocol targets 300+ conditions responsible for 80%+ of premature deaths. Achieved 26% clinically meaningful detection rate in 1,500+ initial scans, with 4% identifying critical conditions in completely asymptomatic individuals.

💡 Competitive Edge

Cent differentiates through its proprietary CCNM™ protocol (Cardiac, Cancer, Neurological, Metabolic) designed specifically for the Indian market, integrating full-body MRI, low-dose CT, DEXA, ECG, and 120+ biomarkers with AI-driven synthesis into a single standardized D2C workflow. Unlike global competitors focused on Western markets, Cent offers comprehensive multi-modal screening at ₹27,500-₹40,000 (early access pricing), significantly more affordable than Western counterparts ($2,000-2,500). The platform uniquely targets 300+ conditions responsible for 80%+ of premature deaths with a 26% clinically meaningful detection rate in asymptomatic individuals.

Key Technological Advantage
Integrates advanced multi-modal diagnostics (whole-body MRI, cardiac CT, DEXA, comprehensive biomarkers) with AI-powered synthesis and medical specialist validation into a unified D2C platform. Unlike traditional health checkups that use tiered packages and limited imaging (typically ultrasound only), Cent offers comprehensive imaging with no tiers—one complete scan at ₹27,500-₹40,000 early access price. The Tru10™ scoring system provides organ-level risk assessments, enabling personalized health optimization. Single-purpose, standardized workflow designed specifically for CCNM condition detection ensures consistency and accuracy across all centers.

📈 Funding & Partnerships

Total Funding
$5.0M
Latest Round
Seed ($5.0M, Mar 2026)
Key Investors
OneFlow Holdings, South Park Commons
Partnerships
OneFlow Holdings (Shashank ND's family office - Lead Investor), South Park Commons (Investor - US-based VC firm), Healthcare provider partnerships for specialized imaging centers (in development), Expansion partnerships planned for Pune and Hyderabad markets, Clinical validation partnerships with radiologists and medical specialists

📊 Growth & Traction

Growth Metrics
Conducted 1,500+ scans with 26% showing clinically meaningful findings and 4% identifying critical conditions in asymptomatic individuals; achieved $2M ARR with 50% month-on-month growth
Category
Healthcare AI

💡 Innovation & Intellectual Property

Patents & IP
No registered patents publicly disclosed as of March 2026. Proprietary technologies include CCNM™ protocol and Tru10™ organ-wise scoring system protected as trade secrets and intellectual property.

📊 Market & Competition

Market Position
Early-stage D2C preventive healthcare intelligence platform positioning as India's first dedicated 'zero-symptom' diagnostic service. Targets health-conscious individuals aged 30+, high-net-worth individuals, and executives seeking proactive health screening. Competes in the emerging preventive healthcare segment in India, distinguishing itself from traditional health checkups through comprehensive imaging and AI-powered early disease detection.
Main Competitors
Prenuvo, Function Health, Neko Health
← Back to Home